Ribose is a carbohydrate with the formula C5H10O5, that exists in two forms: D-ribose, which occurs in nature and L-ribose, which is the mirror image of D-ribose and does not occur in nature.
Use in ME/CFS and FM[edit | edit source]
It is used as a supplement for help boost muscle energy, such as for athletes and people with ME/CFS, Fibromyalgia, and coronary artery disease. The theory is that if one supplies the body with the precursors to ATP, then it will be easier for the body to make ATP.
Sources[edit | edit source]
ME/CFS and Fibromyalgia[edit | edit source]
In 2008, a pilot study of 41 patients with ME/CFS or fibromyalgia by Jacob Teitelbaum stated that in: "Approximately 66% of patients experienced significant improvement while on D-ribose [at a dose of 5g, three times a day], with an average increase in energy on the VAS [visual analog scale categories: energy; sleep; mental clarity; and pain intensity] of 45% and an average improvement in overall well-being of 30% (p < 0.0001)." The study authors concluded that "D-ribose significantly reduced clinical symptoms in patients suffering from fibromyalgia and chronic fatigue syndrome". A follow-up study by Teitelbaum and colleagues (2012) lead to similar results. Neither study was placebo controlled.
Notable studies[edit | edit source]
- 2012, Treatment of Chronic Fatigue Syndrome and Fibromyalgia with D-Ribose– An Open-label, Multicenter Study (Abstract)
- 2006, The Use of D-Ribose in Chronic Fatigue Syndrome and Fibromyalgia: A Pilot Study (Abstract)
Risks and side effects[edit | edit source]
D-ribose lowers blood sugar.
Learn more[edit | edit source]
- Wikipedia - Ribose
- Dr Sarah Myhill - D-ribose
- 2016, D-Ribose revisited - CFS Remission
- 2012, D-Ribose
See also[edit | edit source]
References[edit | edit source]
- "D-ribose". Doctor Myhill. Retrieved December 19, 2022.
- McMillen, Matt. "Ribose: Uses and Risks". WebMD. Retrieved December 19, 2022.
- "RIBOSE: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews". WebMD. Retrieved December 19, 2022.
- Teitelbaum, Jacob E.; Johnson, Clarence; St Cyr, John (November 2006), "The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study", Journal of Alternative and Complementary Medicine (New York, N.Y.), 12 (9): 857–862, doi:10.1089/acm.2006.12.857, ISSN 1075-5535, PMID 17109576
- Teitelbaum, Jacob (June 27, 2012). "Treatment of Chronic Fatigue Syndrome and Fibromyalgia with D-Ribose– An Open-label, Multicenter Study". The Open Pain Journal. 5 (1): 32–37. doi:10.2174/1876386301205010032.
- Wu, Beibei; Wei, Yan; Wang, Yujing; Su, Tao; Zhou, Lei; Liu, Ying; He, Rongqiao (October 7, 2015). "Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice". Oncotarget. 6 (33): 34128–34142. ISSN 1949-2553. PMC 4741441. PMID 26452037.
- Han, C.; Lu, Y.; Wei, Y.; Wu, B.; Liu, Y.; He, R. (March 2014). "D -ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation". Cell Death & Disease. 5 (3): e1117–e1117. doi:10.1038/cddis.2014.89. ISSN 2041-4889.